GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Other Stockholders Equity

Beximco Pharmaceuticals (DHA:BXPHARMA) Other Stockholders Equity : BDT1,452 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Other Stockholders Equity?

Beximco Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Dec. 2023 was BDT1,452 Mil.

Beximco Pharmaceuticals's quarterly Other Stockholders Equity increased from Mar. 2023 (BDT1,427 Mil) to Jun. 2023 (BDT1,454 Mil) but then declined from Jun. 2023 (BDT1,454 Mil) to Dec. 2023 (BDT1,452 Mil).

Beximco Pharmaceuticals's annual Other Stockholders Equity increased from Jun. 2021 (BDT1,431 Mil) to Jun. 2022 (BDT1,432 Mil) and increased from Jun. 2022 (BDT1,432 Mil) to Jun. 2023 (BDT1,454 Mil).


Beximco Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Beximco Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Other Stockholders Equity Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,429.31 1,421.65 1,430.54 1,432.38 1,454.28

Beximco Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,427.95 1,427.81 1,426.72 1,454.28 1,452.34

Beximco Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Beximco Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines